Physician profile
Dylan Thomas Homen
NPI 1346760089
$40,788.82
in general payments reported to CMS, 2019-2025
18 companies · $1,953 in 2025
The $1,953 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $99.03 · 2021: $922 · 2022: $25K · 2023: $9,415 · 2024: $2,955 · 2025: $1,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,555 · Education: $5,000 · Food and Beverage: $3,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,554.87 |
| Education | $5,000.00 |
| Food and Beverage | $3,767.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,647.29 | 2022-2025 | |
| Smith+Nephew, INC. | $10,314.80 | 2022-2023 | Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Coblation |
| Stryker Corporation | $2,605.66 | 2019-2025 | Mako, Iconix, Aequalis Perform Reversed |
| Rattan and Associates | $2,571.29 | 2023-2025 | |
| Fx Shoulder Solutions, INC | $1,613.63 | 2023 | |
| Bioventus LLC | $821.57 | 2019-2025 | Durolane, L360 Thigh System, Durolane |
| Medical Device Business Services, INC. | $274.98 | 2021 | |
| Integra Lifesciences Corporation | $146.16 | 2019-2021 | |
| Depuy Synthes Sales INC. | $127.64 | 2020-2025 | Monovisc |
| Next Science LLC | $118.48 | 2021 | |
| Zimmer Biomet Holdings, INC. | $111.52 | 2021 | |
| Globus Medical, INC. | $98.82 | 2023 | Ankle Fracture System |
| Axogen | $96.83 | 2022 | |
| Orthofix Medical, INC. | $90.85 | 2019-2020 | |
| Vericel Corporation | $83.60 | 2023 | Maci |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.00 | 2024-2025 | Bridion |
| Acell, INC. | $18.49 | 2019 | |
| Si-Bone, INC. | $15.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Homen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.